Literature DB >> 11873859

Fibroblast growth factor (FGF)-23 and hypophosphatemic rickets/osteomalacia.

S Fukumoto1, T Yamashita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11873859     DOI： 10.1507/endocrj.48.603

Source DB:  PubMed          Journal:  Endocr J        ISSN： 0918-8959            Impact factor:   2.349


× No keyword cloud information.
  3 in total

1.  Chronic kidney disease and bone metabolism.

Authors:  Junichiro James Kazama; Koji Matsuo; Yoshiko Iwasaki; Masafumi Fukagawa
Journal:  J Bone Miner Metab       Date:  2015-02-05       Impact factor: 2.626

2.  Selective blood sampling for FGF-23 in tumor-induced osteomalacia.

Authors:  Hans-Christof Schober; Christian Kneitz; Franziska Fieber; Kathrin Hesse; Henry Schroeder
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-10-06

3.  Phosphaturic mesenchymal tumors among elderly patients: a case report and review of literature.

Authors:  Zaina Adnan; David Nikomarov; Michal Weiler-Sagie; Noga Roguin Maor
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.